Prospects for vaccines during pregnancy and in the newborn period

Clinics in Perinatology

Volumn 24, Issue 1, 1997, Pages 231-249

  Fischer, G W ^a   Ottolini, M G ^a   Mond, J J ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; STREPTOCOCCUS VACCINE; TETANUS TOXOID; VACCINE;

ARTICLE; BCG VACCINATION; CLINICAL TRIAL; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; IMMUNOREACTIVITY; IMMUNOTHERAPY; INFECTION PREVENTION; MATERNAL DISEASE; MOTHER FETUS RELATIONSHIP; NEWBORN INFECTION; POLIOMYELITIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; STREPTOCOCCUS INFECTION; TETANUS; TETANUS PROPHYLAXIS; TUBERCULOSIS; VIRUS TRANSMISSION;

EID: 0030992379     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0095-5108(18)30194-5     Document Type: Article

References (85)

1. Amstey M. The potential for maternal immunization to protect against neonatal infections Semin Perinatol 15 1991 206 209
2. Anderson G. Smithee L. Rados M. Progress toward elimination of haemophilus influenzae type B disease among infants and children: United States, 1987-1993 MMWR Morb Mortal Wkly Rep 43 1994 144 148
3. Baker C. Rench M. Edwards M. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus N Engl J Med 319 1988 1180 1185
4. Baker C. Vaccine prevention of group B streptococcal disease Pediatr Ann 22 1993 711 714
5. Baltazar J. Sarol J. Prenatal tetanus immunization and other practices associated with neonatal tetanus Southeast Asian J Trop Med Public Health 25 1994 132 138
6. Bart K. Foulds J. Patriarca P. Global eradication of poliomyelitis: Benefit-cost analysis Bull World Health Organ 74 1996 35 45
7. Bishop R. The present status of rotavirus vaccine development Southeast Asian J Trop Med Public Health 19 1988 429 435
8. Britt W. Fay J. Seals J. Formulation of an immunogenic human cytomegalovirus vaccine: Responses in mice J Infect Dis 171 1995 18 25
9. Bulkow L. Wainwright R.L. Letson G. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants Pediatr Infect Dis J 12 1993 484 492
10. Burkhardt A. Brunswick M. Bolen J. Anti-immunoglobulin stimulation of B lymphocytes activates Sro-related protein-tyrosine kinases Proc Natl Acad Sci U S A 88 1991 7410
11. Cambier J. Vitetta E. Kettiman J. B-cell tolerance: III Effect of papaine-medicated cleavage of cell surface IgD on tolerance susceptibility of murine B cells. J Exp Med. 146 1977 107 117
12. Chanock R. Kapikian A. Mills J. Influence of immunological factors in respiratory syncytial virus disease Arch Environ Health 21 1970 347 355
13. Child Survival Project, Ministry of Health, Egypt, WHO: Progress toward elimination of neonatal tetanus: Egypt, 1988-1994 MMWR Morb Mortal Wkly Rep 45 1996 4
14. Colditz G. Berkey C. Mosteller F. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analyses of the published literature Pediatrics 96 1995 29 35
15. Cook R. Galazka A. Eliminating neonatal tetanus: An attainable goal Arch Dis Child 60 1985 401 402
16. Delage G. Remy-Prince S. Montplaisir S. Combined active-passive immunization against the hepatitis B virus: Five-year follow-up of children bom to hepatitis B surface antigen-positive mothers Pediatr Infect Dis J 112 1993 126 130
17. del Canho R. Grosheide P. Gerard L. Hepatitis B vaccination and preterm infants Pediatr Infect Dis I 12 1993 407 408
18. Demmler G.J. Congenital cytomegalovirus and disease Adv Pediatr Infect Dis 11 1996 135 162
19. De-xiang D. Xi-Min H. Wan-Jun L. Immunization of neonates with trivalent oral poliomyelitis vaccine (sabin Bull World Health Organ 64 1986 853 860
20. Disanto J. Bonnefoy J. Gauchat J. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM Nature 361 1993 541
21. Durandy A. Basile G. Lisawska-Grospierre J. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns J Immunol 154 1995 1560
22. Durandy A. Thuiller L. Forveille M. Phenotype and functional characteristics of human newborn's B lymphocytes J Immunol 44 1990 60
23. Englund J. Passive protection against respiratory syncytial virus disease in infants: The role of maternal antibody Pediatr Infect Dis J 13 1994 449 453
24. Englund J. Glezen W. Turner C. Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type B vaccines J Infect Dis 171 1995 99 105
25. Englund J. Piedra P. Kasel J. IgG and IgA antibody in breast milk following postpartum immunization with respiratory syncytial virus purified fusion protein vaccine or trivalent inactivated influenza virus vaccine [abstract #67] Infectious Disease Society of America 1996 48
26. Fine P. The BCG story: Lessons from the past and implications for the future Reviews on Infectious Diseases 11 1989 S353 365
27. Fischer G. Use of intravenous globulin to prevent or treat infections Adv Pediatr Infect Dis 7 1992 85 108
28. Fischer G. Weisman L. Hemming V. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: A review Clin Immunol Immunopathol 62 1992 S92 97
29. Flores J. Perez-Schael I. Blanco M. Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine J Clin Microbiol 31 1993 2439 2445
30. Gill T. Repetti C. Metlay L. Transplacental immunization of the human fetus by immunization of the mother J Clin Invest 72 1983 987 996
31. Glass R. Gentsch J. Smith J. Rotavirus vaccines: Success by reassortment Science 265 1994 1389 1391
32. Glezen J. Englund J. Siber G. Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type B J Infect Dis 165 1992 S134 S136
33. Glezen J. Paredes A. Allison J. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level J Pediatr 98 1981 708 715
34. Graham B. Henderson G. Tang Y. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus J Immunol 151 1993 4
35. Groothuis J. Simoes E. Levin M. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children N Engl J Med 329 1993 1524 1530
36. Hall C. Wash E. Long C. Immunity to and frequency of reinfection with respiratory syncytial virus J Infect Dis 163 1991 693 698
37. Harrison C. Britt W. Chapman N. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model J Infect Dis 172 1995 1212 1220
38. Kapikian A. Mitchell R. Chanock R. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine Am J Epidemiol 89 1969 405 421
39. Katz M. Plotkin S. Oral polio immunization of the newborn infant: A possible method for overcoming interference by ingested antibodies J Pediatr 73 1968 267 270
40. Kohler P. Dubois R. Merrill D. Prevention of chronic neonatal hepatitis B virus infection with antibody to the hepatitis B surface antigen N. Engl J Med. 291 1974 1378 1380
41. Kurikka S. Kayhty H. Peltola H. Neonatal immunization: Response to Haemophilus influenzae type B-tetanus toxoid conjugate vaccine Pediatrics 95 1995 815 822
42. Kurikka S. Kayhty H. Sarrinen L. Comparison of five different schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine J Pediatr 128 1996 524 530
43. Lamprect C. Krause H. Mufson M. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus J Infect Dis 134 1976 211 217
44. Lehman D. Epidemiology of acute respiratory tract infections, especially those due to haemophilus influenza in Papua, New Guinean children J Infect Dis 165 1992 520 525
45. Levitt D. Haber P. Rich K. Hyper IgM immunodeficiency: A primary dysfunction of B lymphocyte isotype switching J Clin Invest 72 1983 1650
46. Lieberman J. Greenberg D. Wong V. Effect of neonatal immunization with diphtheria and tetanus toxoid on antibody response to Haemophilus influenzae type b conjugate vaccines J Pediatr 122 1995 198 205
47. Linder N. Handsher R. Fruman O. Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity Pediatr Infect Dis J 13 1994 959 962
48. Lindsberg M. Brunswick M. Yamada H. Biochemical analysis of the immune B cells defect in xid mice J Immunol 147 1991 3774
49. Madoff L. Paoletti L. Tai J. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta 1 C protein in conjugate elicits protective antibody to multiple serotypes J Clinic Invest 94 1994 286 292
50. Maupas P. Chiron J. Barin F. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children: Controlled trial in an endemic area (Senegal Lancet i 1981 289 292
51. Metcalf E. Linman N. In vitro tolerance induction of neonatal murine B cells J Exp Med 143 1976 1327
52. Miyawakl T. Kibagawa J. Butler J. Ig isotopes produced by EBV transformed B cells as a function of age and tissue distribution J Immunol 140 1988 3887 3892
53. Mohle-Boetani J. Ajello G. Breneman E. Carriage of Haemophilus influenzae type B in children after widespread vaccination with conjugate Haemophilus influenzae type B vaccines Pediatr Infect Dis J 12 1993 589 593
54. Mohle-Boetani J. Schuchat A. Plikaytis B. Comparison of prevention strategies for neonatal group B streptococcal infection: A population-based economic analysis JAMA 270 1993 1442 1448
55. Muholland K. Suara R. Siber G. Maternal immunization with Haemophilus influenzae type B polysaccharide-tetanus protein conjugate vaccine in the Gambia JAMA 275 1996 1182 1188
56. Murphy B. Prince G. Wash E. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine J Clin Microbiol 24 1986 197 202
57. Murphy B. Sotnikov A. Lawrence L. Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization Vaccine 8 1990 450 497
58. Nemazee D. Burki K. Clonal detection of autoreactive B lymphocytes in bone marrow chimeras Proc Natl Acad Sci U S A 86 1989 8039
59. Nonoyama S. Penix L. Edwards C. Diminished expression of CD40 ligand by activated neonatal T cells J Clin Invest 95 1995 66 75
60. Norvelle A. Mandik L. Monroe J. Engagement of the antigen-receptor on immature B lymphocytes results in death by apoptosis J Immunol 154 1995 4404
61. O'Brien K. Ruff A. Louis M. Bacillus Calmette-Guerin complications in children born to HIV-l-infected women with a review of the literature Pediatrics 95 1995 414 418
62. Ogilvie M. Vathenen A. Radford M. Maternal antibody and respiratory syncytial virus infection in infancy J Med Virol 7 1981 263 271
63. Ottolini M. Hemming V. Respiratory syncytial viral infection: An old problem presents new challenges Infect Med 11 1994 347 360
64. Plotkin S. Katz M. Brown R. Oral poliovirus vaccination in newborn african infants: The inhibitory effect of breast feeding American Journal of Diseases in Children 111 1966 27
65. Report for the Committee on Infectious Diseases: Hepatitis B American Academy of Pediatrics Red Book 1994 224 238
66. Ruff T. Gertig D. Otto B. Lombok hepatitis B model immunization project: Toward universal infant hepatitis B immunization in indonesia J Infect Dis 171 1995 290 296
67. Sabin A. Michaels R. Krugman S. Excretion of virus after ingestion of large doses of type 1 or of mixture of all three types, in relation to level of placentally transmitted antibody Pediatrics 31 1963 623 641
68. Schofield F. Tucker V. Neonatal tetanus in New Guinea: Effect of active immunization in pregnancy Br Med J 2 1961 785 789
69. Schuchat A. Wenger J. Epidemiology of group B streptococcal disease: Risk factors, prevention strategies, and vaccine development Epidemiol Rev 16 1994 374 402
70. Shahid N. Steinhoff M. Hoque S. Serum, breast milk, and infant antibody after maternal immunization with pneumococcal vaccine Lancet 346 1995 1257
71. Splawski J. Jelinek D. Lipsky P. Delineation of the functional capacity of human neonatal lymphocytes J Clin Invest 87 1991 545 553
72. Splawski J. Nishioka J. Nishioka Y. CD40 ligand is expressed and functional on activated neonatal T cells J Immunol 156 1996 119
73. Stoll B. Lee F. Hale E. Immunoglobulin secretion by the normal and the infected newborn infant J Pediatr 122 1993 780 786
74. Takala A. Santosham M. Almeido-Hill J. Vaccination with Haemophilus influenzae type B meningococcal protein conjugate vaccine reduced oropharyngeal carriage of Haemophilus influenza type B among American Indian children Pediatr Infect Dis J 12 1993 593 599
75. Tosato G. Magreth T. Koski E. B cell differentiation and immuno-regulatory T cell function in human cord blood lymphocytes J Clin Invest 66 1980 383
76. Vitetta E. Uhr J. Immunoglobulin-receptors revisited Science 189 1975 964 989
77. fgrl J Immunol 154 1995 1919 1929
78. Weiner H. Moorhead J. Claman H. Anti-lg stimulation of murine lymphocytes: I Age dependence of the proliferative response. J Immunol. 116 1976 1656
79. Wessels M. Paoletti L. Pinel J. Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine J Infect Dis 171 1995 879 884
80. Wessels M. Paoletti L. Rodewald A. Stimulation of protective antibodies against type la and lb group B streptococci by a type la polysaccharide-tetanus toxoid conjugate vaccine Infection and Immunity 61 1993 4760 4766
81. Whitley R. Prospects for vaccination against herpes simplex virus Pediatr Arm 22 1993 726 732
82. World Health Organization: News and activities: Expanded programme on immunization for the 1990s WHO Bull 1992 392 393 12 Jan
83. World Health Organization: Global advisory group of the expanded programme on immunization WHO, Wkly Epid Record 1990 9 10 12 Jan
84. Yellen A. Glenn W. Sukhatme V. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice J Immunol 146 1991 1446 1454
85. Yusuf B. Solter S. Bertsch D. Impact of a tetanus toxoid immunization mass campaign on neonatal tetanus mortality in Aceh Province, Indonesia Southeast Asian J Trop Med Public Health 22 1991 351 356